Conversa Health
About Conversa Health
Conversa Health, founded in 2014, is a virtual care platform that specializes in automated patient engagement and management. The company’s core offering is a conversational AI technology that facilitates personalized, automated doctor-patient communication. This platform aims to bridge the gap in healthcare by providing continuous interaction between patient and provider, particularly outside of traditional office visits. Conversa’s technology builds robust patient profiles using various data sources, including electronic health records (EHRs), biometric wearables, and self-reported patient data, to deliver clinically intelligent and personalized conversations.
For physicians, Conversa Health acts as an automated member of the care team, enabling them to virtually engage, monitor, and manage patient populations more effectively and efficiently. The platform offers an extensive library of clinically intelligent conversation programs for a wide range of use cases, including chronic condition management (e.g., asthma, COPD, CHF, diabetes, hypertension), acute discharge, perioperative care, oncology, OBGYN, prevention, and wellness. By automating routine communications and collecting patient-generated health data, Conversa helps physicians gain unprecedented visibility into their patients’ well-being, optimize the use of telehealth and in-person consults, and ultimately improve patient satisfaction, adherence to care plans, and clinical outcomes.
In 2021, Conversa Health was acquired by Amwell, a national telehealth leader, for approximately $320 million in stock and cash. This acquisition aimed to integrate Conversa’s automated virtual healthcare capabilities into Amwell’s broader virtual care platform, accelerating a hybrid care delivery model that blends in-person, virtual, and automated interactions. The combined entity focuses on enhancing care quality, access, and experience, while driving better health outcomes and shifting healthcare from reactive to proactive, episodic to continuous, and hospital to home.
Focus Areas
Business Intelligence
| Key Investors | Builders VC, Northwell Ventures, UH Ventures, P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health, Nassau Street Ventures, Healthgrades, Allscripts, Triple Tree |
| Partnerships | Northwell Health, UCSF Health, UNC Health, University Hospitals, Prisma Health, SCL Health |
| Acquisitions | Acquired by Amwell in 2021 for approximately $320 million (along with SilverCloud Health) |
| Technology | Automated Virtual Care and Triage™ platform, proprietary patient profiling and health signals engine, extensive library of evidence-based digital pathways, conversational AI technology, EHR integration, biometric device integration, cloud-native |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
Conversa Health's platform acts as an automated member of the care team, allowing highly-trained healthcare professionals to practice at the top of their licenses by automating routine communication and care tasks. Physicians gain insights into patient health between visits through collected patient-generated health data and biometric readings, enabling proactive interventions and personalized guidance. The system also triages patients to higher levels of care (e.g., phone calls, telehealth, in-person consults) when necessary, optimizing resource allocation. This can lead to improved patient satisfaction, reduced hospital readmission rates, and increased revenue through better adherence to care plans and reduced no-show rates.
Conversa is designed as an enterprise solution that integrates with other critical systems, including Electronic Health Records (EHRs), telehealth platforms, and remote patient monitoring (RPM) devices. This allows for a seamless flow of data and a comprehensive view of the patient's health journey.
What the Web Says
Conversa Health, acquired by Amwell, offers a text-based care plan management platform utilizing conversational AI to help patients manage chronic and post-acute care, report outcomes, and engage with their care plans. The platform aims to automate aspects of communication and care, triaging patients to higher levels of care when necessary. Employee reviews indicate a generally positive workplace culture, though some older reviews mention a shift in work-life balance and a stressful environment during the pandemic due to the critical nature of their platform.
Overall: MixedStrengths
- Automated virtual care platform for patient engagement and management.
- Utilizes conversational AI for patient interaction and health monitoring.
- Helps healthcare organizations manage patients across various care continuums (chronic, post-acute, ER, perioperative, oncology, OBGYN, pediatrics).
- Positive employee sentiment regarding leadership commitment, team compassion, honesty, and communication (older reviews).
- Reported to reduce post-acute care by 20% for one customer.
- HIPAA Compliant.
Limitations
- Limited recent employee reviews available on major platforms like Glassdoor and Comparably, with most positive reviews dating back several years.
- Some older employee reviews mention a shift in focus away from work-life balance and a stressful work environment, particularly during the pandemic.
- Specific product reviews from G2, Capterra, and Reddit are not readily available or are limited.
- The company profile on some review sites is unclaimed or has pending reviews.
Based on reviews from: Indeed.com, Comparably, Elion, The Silicon Review, Shortlister, Mile7, AVIA Marketplace: Resources, Rannkly, Accountable Blog, StartupTalky, Scribd (Inc 5000 List 2021 Someka V1F), VC News Daily, Facebook (UCSC Digital Health Awards), Telehealth and Telecare Aware, Calagator: Portland's Tech Calendar, Georgetown University (Health Care Litigation Tracker)
Last updated: 2026-08-24
Videos
News, demos, and interviews about Conversa Health.
Videos load interactively. If none appear, search YouTube for Conversa Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Conversa Health.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]